Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
November 2016

Recent Stories

From Specialty Pharmacy News - Providing oncologists real-time clinical support for selecting treatment regimens speeded up one insurer’s approval process and reduced its drug costs by 20% in one state, according to a recently published article in the American Society of Clinical Oncology’s Journal of Oncology Practice. The article, which was published online Oct. 24, examined a pilot program in which UnitedHealthcare implemented a digital version of the National Comprehensive Cancer Network’s (NCCN) Clinical Practice Guidelines in Oncology to be used as a prior-authorization tool offering real-time decision support. Read more

With Republican Donald Trump being declared the next U.S. president and the… Read more

The FDA recently approved the first drug to address the underlying problem… Read more

Having had success with its collaborative care deals with large primary care… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

December 2, 2016
CMS Releases 2015 National Health Expenditures Data

CMS reports that spending on prescription drugs rose 9.0% in 2015, down from 12.4% growth in 2014 but an increase from 2.3% in 2013

October 25, 2016
FDA OKs Keytruda as First Checkpoint Inhibitor for 1st Line Lung Cancer Treatment

FDA approved Merck’s Keytruda to treat metastatic NSCLC in people with high PD-L1 expression. It’s the first checkpoint inhibitor approved as 1st line treatment for lung cancer. Agency also expanded 2nd line indication to all PD-L1-expressing NSCLC

October 17, 2016
Biden Delivers Moonshot Report

Vice President Biden issues final Cancer Moonshot report to president, will address public this afternoon

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?